BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9699859)

  • 1. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling.
    Desvergne B; IJpenberg A; Devchand PR; Wahli W
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):65-74. PubMed ID: 9699859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
    Takeyama K; Kodera Y; Suzawa M; Kato S
    Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological and pharmacological function of PPARs].
    Takahashi N; Kawada T
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):319-27. PubMed ID: 11411341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes.
    Hunter J; Kassam A; Winrow CJ; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1996 Feb; 116(2):213-21. PubMed ID: 8647322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
    Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Clemencet MC; Jannin B; Berlot JP
    Biochem Pharmacol; 2000 Oct; 60(8):1027-32. PubMed ID: 11007938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator activated receptors and obesity.
    Kersten S
    Eur J Pharmacol; 2002 Apr; 440(2-3):223-34. PubMed ID: 12007538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
    Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.